In November 2023, leveraging the profound expertise in nanotechnology of our parent company, DAZZEON Technology, our company proudly launched a pioneering research initiative focused on nanofabrication processes and the preservation of biological activity.
This project is at the forefront of exploring how polysaccharides and other natural substances can be nano-engineered to serve as active ingredients or drug carriers, all while maintaining their inherent biological activities. Our aim is to utilize plant-based materials to develop a new generation of pharmaceuticals and medical devices, demonstrating the vast potential of nanotechnology applications in the biomedical field.